Victoria Blinder

Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)

Jonas A. de Souza, Bonnie J. Yap, Kristen Wroblewski et al. · Cancer · 2016 · 819 citations · Full text

Quality Of Life, Cancer Management, Clinical Endpoint +17

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer

Ethan Basch, Deborah Schrag, Sydney Henson et al. · JAMA · 2022 · 337 citations · Full text

American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations

Jennifer J. Griggs, Shail Maingi, Victoria Blinder et al. · Journal of Clinical Oncology · 2017 · 249 citations

Family Medicine, Cancer Care Continuum, Health Care Disparity +25

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

Sara M. Tolaney, Elizabeth Garrett‐Mayer, Julia White et al. · Journal of Clinical Oncology · 2021 · 192 citations · Full text

Return to work in low‐income Latina and non‐Latina white breast cancer survivors: A 3‐year longitudinal study

Victoria Blinder, Sujata Patil, Amardeep Thind et al. · Cancer · 2011 · 104 citations · Full text